MAHA may take aim at pharma DTC ads

RFK Jr. has his sights set on increasing oversight and enforcement against drugmakers that run afoul of advertising laws.

Lilly says it will raise drug prices in Europe, responding to Trump threats

As the Trump administration works to implement a “most-favored nation” policy, Lilly said it’s “rebalancing” prices to “align” costs across different countries.

The state of drug pricing in 2025

CSL to separate vaccine business, cut jobs

On an earnings call, CSL CEO Paul McKenzie described weakness in the U.S. market for seasonal flu vaccines as “disappointing” and “highly irrational.”

Stealth resubmits rare disease drug to FDA

The biotech, which cut jobs following the rejection in May of its Barth syndrome therapy, claimed it has addressed the agency’s concerns and now sees potential for a speedy review.

WeightWatchers Bets on Community in the GLP-1 Era

Large employers forecast ‘daunting’ 9% hike in healthcare costs next year

Tonix Wins Approval For First New Fibromyalgia Drug in Over 15 Years